Skip to main content

Table 3 Physician agreement with the evidence for tPA use in acute stroke care (n = 429)

From: Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey

Statement Disagree/strongly disagree n (%) Unsure n (%) Agree/strongly agree n (%)
Increasing appropriate use of tPA will:
 Save lives 185 (43.1) 155 (36.1) 89 (20.7)
 Not result in unnecessary adverse events 267 (62.3) 102 (23.8) 60 (14.0)
 Improve the odds of independent survival for stroke patients 109 (25.4) 150 (35.0) 170 (39.6)
The evidence underpinning tPA use:*
 Is strong when administered within 4.5 h of stroke onset 226 (54.4) 119 (28.7) 70 (16.8)
 Indicates that the benefits outweigh the risks if the treatment protocol is followed 134 (32.3) 107 (25.8) 173 (42.0)
 Is strong enough to warrant the use of this treatment 141 (34.0) 119 (28.7) 155 (37.4)
  1. Number of observations varies across items due to missing data.
  2. * n = 415.
\